Page
%P
-
Article
Nanoparticle delivery for central nervous system diseases and its clinical application
In the treatment of central nervous system (CNS) diseases such as glioma, Alzheimer’s disease (AD) and Parkinson’s disease (PD), drugs are expected to reach specific areas of the brain to achieve the desired e...
-
Article
Open AccessRational design of innate defense regulator peptides as tumor vaccine adjuvants
The development of adjuvants has been an empirical process. Efforts to develop a new design and evaluation system for novel adjuvants are not only desirable but also necessary. Moreover, composite adjuvants th...